SMCI stock drops on weak Q3 results, analysts issue mixed ratings. Needham reinstates Buy rating with $39 PT, Wedbush neutral with $30 PT, JP Morgan lowers PT to $35. Company faces near-term headwinds but has strong long-term potential.
Latest Ratings for SMCI
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 2021 | Susquehanna | Maintains | Positive | |
| May 2021 | Northland Capital Markets | Maintains | Outperform | |
| Jun 2020 | Northland Capital Markets | Initiates Coverage On | Outperform |
